If you are at high risk for severe illness from COVID-19, you may qualify for antiviral treatments, including oral antiviral treatments. Montefiore Medical Center will be offering prescriptions for Nirmatrelvir/Ritonavir (Paxlovid), Lagevrio (Molnupiravir), or appointments for IV Remdesivir as the most effective treatments against the current Omicron subvariants.
Speak with your healthcare provider about which therapy is most appropriate for you, or contact us at firstname.lastname@example.org.
Starting early December 2022, patients presenting within seven days of symptoms who are at highest risk for severe COVID-19 due to moderate-to-severe immunocompromise, and who cannot receive oral antivirals, may be eligible for a three-day consecutive course of outpatient IV remdesivir at the Montefiore COVID-19 Outpatient Therapeutics Program at 1575 Blondell Avenue, Bronx, NY 10461. Treatment will be offered Monday – Friday. Patients must be willing to come to our infusion center for three consecutive days. Others will be offered oral antiviral medications if no contraindications.
There are two oral antivirals available under Emergency Use Authorization by the FDA. These are nirmatrelvir/ritonavir (Paxlovid) and Molnupiravir. The first is preferred because of greater effectiveness against COVID-19. Unlike monoclonal antibodies, these agents can be taken at home. As with monoclonal antibodies, patients are eligible if they have recently developed COVID-19, have tested positive by PCR or antigen test, and have any high risk condition listed below. A prescription can be sent by your healthcare provider, or your provider can consult our program at the information listed below. You must be within five days of onset of your symptoms to qualify.
To qualify, you must have tested positive for COVID-19 recently (by antigen or PCR test); have mild to moderate symptoms that are managed without oxygen support; and fall into one of the high risk categories below. These treatments are not for patients who are hospitalized for COVID-19.
You're eligible if you have any ONE of the following:
- Older Age (for example, 55-65 years and up)
- Chronic heart disease
- COPD/chronic respiratory disease, including moderate asthma or emphysema
- Diabetes (Type 1 or Type 2) on chronic medications
- Chronic kidney disease
- Immunosuppression due to a chronic medical condition (for example, active cancer, HIV, organ transplant, and others)
- You're taking medicine that weakens your immune system
- Pregnant (or recently delivered)
- Neurodevelopmental, genetic, or metabolic disorder like Cerebral Palsy
- Member of a racial or ethnic minority group at increased risk for severe Covid-19
- Sickle Cell Disease
- Medical technology dependent (trach, feeding tube, etc.)
12 to 17 years of age and at least 40 kg (88 pounds) with any of the following:
- BMI greater than or equal to 85 percent of patients of the same age and gender
- Regularly uses medical technology such as a ventilator or feeding tube
- Have a developmental condition like cerebral palsy
- Sickle cell disease
- Congenital or acquired heart disease
- Asthma/chronic respiratory problems requiring daily medication for control
Longstanding inequities and chronic disease have led to high COVID-19 infection rates and significant risk of death in the Bronx. Now Bronx residents have a safe, evidence-based treatment that stops COVID-19 in its tracks and is preventing severe illness.